Which protein is the primary carrier for basic drugs in plasma?

Prepare for the Clinical Chemistry Numericals Test. Study with comprehensive questions, each with detailed explanations. Boost your confidence and excel on your exam!

Multiple Choice

Which protein is the primary carrier for basic drugs in plasma?

Explanation:
Basic drugs in plasma are mainly bound by alpha-1 acid glycoprotein because this protein carries negative charges from sialic acid residues, making it a favorable partner for positively charged (cationic) drugs. The ionic interactions between the positively charged drug and the negatively charged binding sites on the glycoprotein reduce the free drug concentration, influencing distribution and clearance. Albumin tends to bind acidic or neutral drugs, due to its own negative surface charges, while haptoglobin and ceruloplasmin have other primary roles—haptoglobin binds free hemoglobin, and ceruloplasmin transports copper and acts as an enzyme—so they are not the main carriers for basic drugs. Be aware that alpha-1 acid glycoprotein levels can rise during inflammation, which can further affect how much basic drug is free versus bound and thereby impact pharmacokinetics.

Basic drugs in plasma are mainly bound by alpha-1 acid glycoprotein because this protein carries negative charges from sialic acid residues, making it a favorable partner for positively charged (cationic) drugs. The ionic interactions between the positively charged drug and the negatively charged binding sites on the glycoprotein reduce the free drug concentration, influencing distribution and clearance. Albumin tends to bind acidic or neutral drugs, due to its own negative surface charges, while haptoglobin and ceruloplasmin have other primary roles—haptoglobin binds free hemoglobin, and ceruloplasmin transports copper and acts as an enzyme—so they are not the main carriers for basic drugs. Be aware that alpha-1 acid glycoprotein levels can rise during inflammation, which can further affect how much basic drug is free versus bound and thereby impact pharmacokinetics.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy